Categories Technology

AT&T earnings preview: Will Q2 results exceed expectations?

AT&T (T) is scheduled to announce its June quarter earnings results on July 24 after the market close. Most of the analysts are looking for the telecom veteran to post upbeat earnings for the recently concluded quarter while predicting a decline in revenue. Wireless and entertainment group additions would be the main focus of the investors.

In the recent first-quarter, the telecom giant posted a 34% jump in earnings driven by the actuarial gain on benefit plans and costs for amortization, merger- and integration-related expenses. However, revenues dropped 3.4% due to declines in legacy wireline services, domestic video, and wireless service revenues.

At the end of the first quarter, AT&T had about 55 million business wireless subscribers. Total video subscribers grew by 125,000 and the Entertainment Group ended the quarter with 25.4 million total video subscribers. DIRECTV NOW added 312,000 subscribers to reach nearly 1.5 million customers.

Related: AT&T reports Q1 2018 results; misses estimates

With regard to the AT&T-Time Warner merger, a federal appeals court approved the US Justice Department’s request for an accelerated schedule for an appeal of a judge’s ruling. The legal briefs must be closed by October 18. The department fears that the merged company will have the ability to raise its rivals’ costs and stifle growth on next-gen entrants.

For the second quarter, market analysts expect the company to report a 7.6% increase in earnings and a 1.1% decline in revenue. In the past four quarters, the company’s earnings missed Street’s expectations for two times, while beating predictions for two times. Majority of the analysts are recommending a HOLD rating on the stock.

Shares of AT&T closed Thursday’s regular trading session down 1.39% at $31.27 on the NYSE and reached a new 52-week low ($31.04) during Friday’s morning trading session.

Related: DOJ unwilling to let go, plans appeal against AT&T-Time Warner deal

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top